Prestige Consumer Healthcare to Release Fiscal 2026 First Quarter Earnings Results
Prestige Consumer Healthcare (NYSE:PBH) has scheduled its fiscal 2026 first quarter earnings release for Thursday, August 7, 2025, before market opening. The company will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results.
Investors can access the live webcast through the company's Investor Relations webpage at prestigeconsumerhealthcare.com. For phone participation, registration is required to receive dial-in details and a unique pin. A replay of the conference call will be available for approximately one week on the company's IR page.
Prestige Consumer Healthcare (NYSE:PBH) ha programmato la pubblicazione dei risultati del primo trimestre fiscale 2026 per giovedì 7 agosto 2025, prima dell'apertura del mercato. La società terrà una conference call e una diretta webcast alle 8:30 a.m. ET dello stesso giorno per discutere i risultati.
Gli investitori potranno accedere alla diretta webcast tramite la pagina Investor Relations dell'azienda all'indirizzo prestigeconsumerhealthcare.com. Per partecipare telefonicamente, è necessaria la registrazione per ricevere i dettagli di accesso e un codice PIN univoco. La registrazione della conference call sarà disponibile per circa una settimana sulla pagina IR della società.
Prestige Consumer Healthcare (NYSE:PBH) ha programado la publicación de sus resultados del primer trimestre fiscal 2026 para el jueves 7 de agosto de 2025, antes de la apertura del mercado. La compañía realizará una llamada de conferencia y una transmisión en vivo a las 8:30 a.m. ET del mismo día para analizar los resultados.
Los inversores podrán acceder a la transmisión en vivo a través de la página de Relaciones con Inversores de la empresa en prestigeconsumerhealthcare.com. Para participar por teléfono, es necesario registrarse para recibir los detalles de acceso y un PIN único. La repetición de la llamada estará disponible durante aproximadamente una semana en la página IR de la empresa.
Prestige Consumer Healthcare (NYSE:PBH)는 2025년 8월 7일 목요일, 시장 개장 전인 2026 회계연도 1분기 실적 발표를 예정하고 있습니다. 같은 날 동부시간 오전 8시 30분에 실적 관련 컨퍼런스 콜과 웹캐스트를 진행할 예정입니다.
투자자들은 회사의 투자자 관계 웹페이지 prestigeconsumerhealthcare.com을 통해 실시간 웹캐스트에 접속할 수 있습니다. 전화 참여를 원할 경우, 등록을 통해 전화 접속 정보와 고유 PIN을 받아야 합니다. 컨퍼런스 콜 녹음은 회사 IR 페이지에서 약 일주일간 다시 들을 수 있습니다.
Prestige Consumer Healthcare (NYSE:PBH) a programmé la publication de ses résultats du premier trimestre fiscal 2026 pour le jeudi 7 août 2025, avant l'ouverture des marchés. La société organisera une conférence téléphonique et une diffusion en direct à 8h30 ET le même jour pour discuter des résultats.
Les investisseurs pourront accéder à la diffusion en direct via la page Relations Investisseurs de l'entreprise sur prestigeconsumerhealthcare.com. Pour participer par téléphone, une inscription est requise afin de recevoir les détails d'accès et un code PIN unique. La rediffusion de la conférence téléphonique sera disponible pendant environ une semaine sur la page IR de la société.
Prestige Consumer Healthcare (NYSE:PBH) hat die Veröffentlichung der Ergebnisse für das erste Quartal des Geschäftsjahres 2026 für Donnerstag, den 7. August 2025, vor Markteröffnung, angesetzt. Das Unternehmen wird am selben Tag um 8:30 Uhr ET eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen.
Investoren können den Live-Webcast über die Investor-Relations-Webseite des Unternehmens unter prestigeconsumerhealthcare.com verfolgen. Für die telefonische Teilnahme ist eine Registrierung erforderlich, um die Einwahldaten und eine individuelle PIN zu erhalten. Eine Aufzeichnung der Telefonkonferenz wird etwa eine Woche lang auf der IR-Seite des Unternehmens verfügbar sein.
- None.
- None.
TARRYTOWN, N.Y., July 15, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 first quarter earnings release on Thursday, August 7, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com
FAQ
When will Prestige Consumer Healthcare (PBH) release its Q1 2026 earnings?
How can investors access PBH's Q1 2026 earnings conference call?
What time is Prestige Consumer Healthcare's Q1 2026 earnings call?
How long will PBH's Q1 2026 earnings call replay be available?
